Managing haematology and oncology patients during the COVID- 19 pandemic: interim consensus guidance

A pandemic coronavirus, SARS- CoV- 2, causes COVID- 19, a potentially life- threatening respiratory disease. Patients with cancer may have compromised immunity due to their malignancy and/or treatment, and may be at elevated risk of severe COVID- 19. Community transmission of COVID- 19 could overwhelm health care services, compromising delivery of cancer care. This interim consensus guidance provides advice for clinicians managing patients with cancer during the pandemic.